Skip to main content

Table 4 Associations between exposure and the health-related outcomes

From: Vascular and lung function related to ultrafine and fine particles exposure assessed by personal and indoor monitoring: a cross-sectional study

 

Personal monitoring

Stationary indoor monitoring (home)

PNC total period (103/cm3)

Exposure at home (103/cm3)*h

Exposure away from home (103/cm3)*h

PNC (103/cm3)

PM2.5_(μg/m3)

Number of subjects

N = 57

N = 57

N = 57

N = 81

N = 72

IQR

6.9

325.3

141.5

5.1

7.4

MVF

−2.6 (-5.2, 0.1)

2.4 (-5.2, 10.5)

−1.3* (-2.5, -0.1)

−0.03 (-2.4, 2.4)

6.7 (-0.4, 14.3)

Baseline pulse amplitude

−9.6* (-15.7, -3.0)

−15.11 (-30.4, 3.6)

−3.4* (-6.4, -0.3)

−1.1 (-8.5, 7.0)

−13.6 (-31.3, 8.6)

Systolic blood pressure

0.7 (-0.6, 2.0)

1.3 (-2.1, 4.8)

0.3 (-0.3, 0.8)

2.4* (0.9, 3.8)

4.6 (-0.003, 9.2)

Diastolic blood pressure

0.3 (-0.5, 1.2)

1.3 (-1.1, 3.7)

0.1 (-0.3, 0.5)

2.3* (1.4, 3.2)

2.8 (-0.4, 6.0)

C-reactive protein

−1.2 (-11.7, 10.7)

−3.1 (-28.5, 31.3)

−0.5 (-5.3, 4.6)

6.1 (-2.2, 15.0)

−4.8 (-14.8, 6.4)

Leukocytes

3.1* (0.3, 5.9)

−0.7 (-7.9, 7.1)

1.5* (0.3, 2.7)

1.1 (-1.2, 3.5)

1.6 (-5.8, 9.5)

Lymphocytes

1.7 (-1.4, 5.0)

2.8 (-5.6, 11.9)

0.6 (-0.7, 2.1)

2.4 (-1.1, 6.0)

13.2* (1.3, 26.6)

Monocytes

−0.8 (-4.6, 3.1)

−6.4 (-15.6, 3.9)

−0.03 (-1.7, 1.7)

1.4 (-3.5, 6.6)

5.8 (-7.6, 21.0)

Neutrophils

5.5* (1.7, 9.4)

1.9 (-8.3, 13.4)

2.4* (0.8, 4.1)

0.7 (-2.6, 4.1)

−3.7 (-13.1, 6.6)

Eosinophils

−3.3 (-8.6, 2.4)

−9.0 (-23.6, 8.6)

−1.0 (-3.4, 1.5)

−5.2* (-9.8, -0.4)

−16.3* (-27.1, -3.9)

FEV1/FVC

−0.6 (-1.4, 0.2)

−1.0 (-3.1, 1.2)

−0.2 (-0.6, 1.1)

0.5 (-0.1, 1.1)

0.7 (-1.2, 2.6)

  1. Percent change (95% confidence interval) in outcome levels associated with an interquartile range (IQR) increase in personal particle number concentration (PNC) monitored for the whole period and personal exposure (concentration times time) at home and away from home estimated with regression models and with stationary home indoor PNC and PM2.5 estimated with generalized estimation equations on the natural logarithm of the outcomes with adjustment for age, gender, and BMI, respectively.
  2. MVF, Microvascular function; FEV1, Forced expiratory volume 1s (L); FVC, Forced vital capacity (L). * p < 0.05.